therapy, supported specifically by double-digit growth in Provena and ongoing expansion of our innovative back peel-in-place dressing. As mentioned earlier, we recently closed the Acera acquisition, which will now be a part of our advanced

Jun 30, 2026 / receipt

On the mission front, we've met with teams around the globe, I traveled around the globe to directly engage our team members and share our new mission and values.

Feb 27, 2025 / receipt, needs a key / Brian Hanson, CEO | earnings call 2025-02-27 | transcript 2cffa685-a782-4581-8c2e-86ef6bb5f9f6 | chars 8742-8904 | segment 9

No dividend or share repurchase at this time

ir_statement / Sep 17, 2026 / receipt

Pay down debt Priority for first ~24 months post transaction close

ir_statement / Sep 17, 2026 / receipt

Adjusted operating income reflects pricing actions partially offset by increase in operating expenses related to public company and functional stand-up costs

ir_statement / Sep 17, 2026 / receipt

Incremental headwinds will impact balance of 2024 post spin-off including costs of stand-alone operations and strategic actions (SKU reduction)

ir_statement / Sep 17, 2026 / receipt

Pricing: Expect waning benefit for remainder of 2024 and a return to a normalized pricing environment

ir_statement / Sep 17, 2026 / receipt

Stand-up functional expenses: expected to ramp up for the remainder of 2024

ir_statement / Sep 17, 2026 / receipt

Raising FY24 guidance: • Organic sales growth 0% to +1%, increase from prior -2% to 0% • Adjusted EPS $6.30 to $6.50, increase from prior $6.10 to $6.40

ir_statement / Sep 17, 2026 / receipt

Raising FY24 organic sales growth and EPS guidance

ir_statement / Sep 17, 2026 / receipt

Adjusted operating income reflects lower gross margins, including the impact from the 3M supply agreement mark-up, and an increase in operating expenses related to public company stand-up costs and gr

ir_statement / Sep 17, 2026 / receipt

Raising FY24 guidance: • Organic sales growth to upper half of 0% to +1.0%, an increase from 0% to +1.0% • Adjusted EPS of $6.50 to $6.65, an increase from $6.30 to $6.50 • FCF of $750M to $850M, an i

ir_statement / Sep 17, 2026 / receipt

Organic growth driven by continued adoption of 360 Encompass revenue cycle management

ir_statement / Sep 17, 2026 / receipt

Raising FY24 organic sales growth and EPS guidance

ir_statement / Sep 17, 2026 / receipt